Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Revenue:
Sales	$ 3,244
Licensing income	700,000
Total Revenue	703,244
Operating expenses
Research and development	839,147	422,294
General and administrative	2,359,706	1,174,547
Total Operating Expenses	3,198,853	1,596,841
Operating Loss	(2,495,609)	(1,596,841)
Other Income/(Expense):
Interest expense	(583,594)	(743,101)
Changes in fair value of contingent purchase consideration (Note 8)	39,027,901	(61,822,197)
Impairment of goodwill (Note 13)		(13,380,377)
Change in fair value of derivative liabilities		709,917
Net Income (loss)	35,948,698	(76,832,599)
Net (loss) attributable to noncontrolling interests (Note 13)	(385,400)	(6,816,405)
Net Income (Loss) Available to Common Stockholders	$ 36,334,098	$ (70,016,194)
Basic	$ 34.02	$ (70.92)
Diluted	$ 14.02	$ (70.92)
Basic	1,068,101	987,288
Diluted	2,591,129	987,288
Comprehensive Income (Loss):
Net Income (Loss)	$ 36,334,098	$ (70,016,194)
Change in foreign currency translation adjustments	15,272	(15,272)
Comprehensive Income (Loss) Available to Common Stockholders	$ 36,349,370	$ (70,031,916)